Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
8hon MSN
Adds Kenvue comment. Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder ...
Starboard Value, the activist investor pushing for changes at Pfizer, unveiled its goals for another healthcare company — ...
Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...
Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol, Band-Aid, Zirtec, Listerine, ...
Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...
Kenvue, Inc. (KVUE – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Anna ...
By Svea Herbst-Bayliss (Reuters) -Hedge fund Starboard Value called consumer products company Kenvue a bargain and said its ...
Target is reducing prices on more than 2,000 items ranging from snacks to toys and cold medicine in an effort to attract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback